Clinical Trial

A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 24, 2023 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
Clinical research can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical study, both positive and negative. The goal is to identify the obstacles and challenges that prevent participation in glioblastoma multiforme clinical study, as well as the reasons for withdrawal or discontinuation. Insights gained from this study will ultimately benefit those with glioblastoma multiforme who may be invited to participate in clinical trial in the years to come.
Trial Details
NCT Number NCT05958485
Lead Sponsor Power Life Sciences Inc.
Conditions Glioblastoma Multiforme
Enrollment 500 participants
Start Date 2024-08
Primary Completion 2025-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2023-07-24